Australian TGA Approves Illuccix® for Prostate Cancer Imaging

Go back to Australian TGA Approves Illuccix® for Prostate Cancer Imaging
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.90 +0.35 (3.32%)
Previous Close $10.55    52 Week High $2.18 
Open $10.80    52 Week Low $0.30 
Day High $10.91    P/E N/A 
Day Low $10.79    EPS $-3.32 
Volume 175,507